ASH 2020 | Data on Real World Evidence (RWE) on AL amyloidosisAL amyloidosis, Conferences10 December 2020
MPE webinar on ASH 2020 myeloma and AL amyloidosis highlightsAL amyloidosis, MPE, Myeloma8 December 2020
ASH 2020 | Certain people with blood cancers and COVID-19 infection vulnerable to severe illnessAL amyloidosis, Conferences, Myeloma6 December 2020
ASH 2020 | The phase III trial Apollo supports administering daratumumab subcutaneously instead of intravenously in relapsed or refractory myeloma patientsConferences, Myeloma5 December 2020
ASH 2020 | Visit our poster on myeloma patient information needs and preferences at ASH 2020!Conferences, MPE, Myeloma5 December 2020
Register now for MPE’s webinar on Evidence-Based Patient AdvocacyMPE, Patient evidence19 October 2020
